Efficacy Study of Weekly Topotecan With Cisplatin in Advanced Stage or Recurrent Cervical Cancer

NCT00322920 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

30

Enrollment

OTHER

Sponsor class

Stopped Low accrual

Conditions

Cervix Cancer

Interventions

DRUG: Topotecan
DRUG: Cisplatin

Sponsor

University of Alabama at Birmingham

Collaborators

[object Object]